At the direction of the U.S. Food and Drug Administration (FDA), Biogen Inc. has added a warning of potential liver injury to the label for its multiple sclerosis medication Tecfidera. According to the FDA warning, “[c]linically significant cases of liver injury have been reported in […]
Feb 1, 2017
By Jessica Hoerman
Tecfidera
